Ушбу иш иқтибос қилган ишлар

8 та иш

Иш: IMMUNOTHERAPEUTIC SIGNIFICANCE OF NTPASE 8 IN ONCOLOGY

1. The ectonucleotidases <scp>CD</scp>39 and <scp>CD</scp>73: Novel checkpoint inhibitor targets

   Bertrand Allard, Maria Serena Longhi, Simon C. Robson +1

   Шарҳ мақола20172 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.020474

2. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

   Julie R. Brahmer, Christina Lacchetti, Bryan J. Schneider +26

   Мақола20182 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.769170

3. Сарлавҳасиз

   Бошқа1 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.769168

4. Сарлавҳасиз

   Бошқа1 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.769169

5. Сарлавҳасиз

   Бошқа1 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.769171

6. Сарлавҳасиз

   Бошқа1 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.769172

7. Сарлавҳасиз

   Бошқа1 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.769173

8. Сарлавҳасиз

   Бошқа1 иқтибос

   ABIABI:AkademIndex/openalex/2026.other.769174